Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Mitomycin

Review the clinical trials studying mitomycin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-16 of 16

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Status: Active
Location: 125 locations
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Status: Active
Location: 74 locations
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Status: Active
Location: 13 locations
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Status: Active
Location: 12 locations
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients with Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Status: Active
Location: 3 locations
Transarterial Chemoembolization for the Treatment of Lung Cancer
Status: Active
Location: 2 locations
Cabozantinib, Ipilimumab, Nivolumab, and Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
Status: Active
Location: 2 locations
A Study Comparing Standard Treatments in People With Non-muscle Invasive Bladder Cancer (NMIBC), COMPARE IT Trial
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Stomach Cancer with Peritoneal Metastases
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Flat Dose or Weight-Based Dose of Mitomycin during Cytoreductive Surgery for the Treatment of Advanced Gastrointestinal Malignancy
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
MnSOD Mimetic BMX-001 in Treating Patients with Anal Cancer Undergoing Radiation Therapy and Chemotherapy
Status: Active
Location: University of Nebraska Medical Center, Omaha, Nebraska
Adaptive Radiotherapy for the Treatment of Patients with Locally Advanced Anal Cancer
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
177Lu-PSMA-617 with Liver Directed Therapy for the Treatment of Castration Resistant Prostate Cancer with Liver Metastasis
Status: Approved
Location: University of California San Francisco, San Francisco, California
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland